Merck Financial Targets Remain On Track, Despite Generic Cozaar, Health Care Reform
This article was originally published in The Pink Sheet Daily
Executive Summary
Key brands contributed strong performance, Schering integration is progressing smoothly without interrupting the business' momentum.
You may also be interested in...
Merck Names Ken Frazier President
The promotion moves Frazier one step closer to becoming CEO and Chairman when Dick Clark retires as expected next year.
Novo Nordisk's GLP-1 Victoza Off To A Good Start
New head-to-head study against popular oral Januvia could bolster case for use as a second-line agent in diabetes, company says.
Chart: Timeline Of Pharma Provisions In Health Care Reform
It is arranged in seven sections, with provisions in each arranged chronologically. If the date is listed as "upon enactment," it means no date was specified in the statute; however, in many cases, regulatory agencies may need to issue guidance or regulations before the provision can be implemented. The information is based on the two health care reform bills: H.R. 3590, which contains the bulk of the reform language, passed the Senate in December, passed the House March 21, and was signed into law March 23; and subsequent fixes in the budget reconciliation bill, H.R. 4872, which cleared the House March 21 and Senate March 25, and the president was expected to sign March 30. The chart also borrows from a comparison chart of pharma provisionsin the two bills by Ian Spatz of Manatt, Phelps & Phillips.